H.C. Wainwright raises Arrowhead Pharma price target to $115 on trial data
H.C. Wainwright raises Arrowhead Pharma price target to $115 on trial data
H.C. Wainwright raises Arrowhead Pharma price target to $115 on trial data
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.